<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Immunohistochemical detection of p53 and pp53 Ser(392) in canine hemangiomas and hemangiosarcomas located in the skin.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Immunohistochemical detection of p53 and pp53 Ser(392) in canine hemangiomas and hemangiosarcomas located in the skin." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359283/bin/12917_2020_2457_Fig3_HTML.jpg"/> </div> <div class="text-side"> <h1>Immunohistochemical detection of p53 and pp53 Ser(392) in canine hemangiomas and hemangiosarcomas located in the skin.</h1> <p>Immunohistochemical expression of proliferative and cell cycle regulatory markers. a Hemangioma. Presence of few Ki-67-positive tumour nuclei. Inset: Positive nuclear expression (arrows). b Well-differentiated hemangiosarcoma. Numerous Ki-67-positive neoplastic nuclei. c Hemangioma. No labeling for p53. d Well-differentiated hemangiosarcoma. Note a high number of neoplastic cells showing strong nuclear expressionÂ for p53. e Hemangioma. No labeling for pp53 Ser392. f Moderately differentiated hemangiosarcoma. Strong nuclear pp53 Ser392 reaction in numerous neoplastic cells. Peroxidase-DAB revelation system, Harris Haematoxylin counterstain. 200x</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32660487/" target="_blank">32660487</a></p><p>Type: Premalignant/Malignant, Category: Vascular</p>
</div> </div></div></body></html>